Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Pfizer Underwrites Basic Research at Shanghai Institutes

publication date: Jul 29, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Pfizer has teamed up with the Shanghai Institutes for Biological Sciences (SIBS) to do basic research. The biggest of pharmas will underwrite $500,000 of health-related basic research projects at SIBS for each of the next three years. Pfizer and SIBS will select the research projects jointly. According to a press release, that initiative is only part of the overall agreement, although no other collaborative activities were disclosed. More details...

Stock Symbol: (NYSE: PFE)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...